Protagonist Therapeutics (PTGX) Long-Term Debt Issuances (2019 - 2023)
Protagonist Therapeutics (PTGX) posted Long-Term Debt Issuances of $24.3 million for Q1 2023, up 66.99% sequentially from $14.6 million in Q1 2022, and up 66.99% YoY from $14.6 million in Q1 2022.
Protagonist Therapeutics (PTGX) Long-Term Debt Issuances (2019 - 2023) Analysis & Trends
Protagonist Therapeutics has reported Long-Term Debt Issuances for 4 years, with the latest figure at $24.3 million in Q1 2023.
- Quarterly Long-Term Debt Issuances rose 66.99% year-over-year to $24.3 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $24.3 million (up 66.99% YoY) and the FY2023 annual result came in at $24.3 million, up 66.99% from the prior year.
- Long-Term Debt Issuances advanced to $24.3 million in Q1 2023 per PTGX's latest filing, from $14.6 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $34.0 million in Q3 2019 and troughed at -$24.7 million in Q4 2019.
- A 4-year average of $12.2 million and a median of $16.7 million in 2020 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 176.2% in 2020, down 81.23% in 2020.
- Over 4 years, Long-Term Debt Issuances stood at -$24.7 million in 2019, then jumped by 176.2% to $18.8 million in 2020, then decreased by 22.77% to $14.6 million in 2022, then jumped by 66.99% to $24.3 million in 2023.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $24.3 million, $14.6 million, and $18.8 million for Q1 2023, Q1 2022, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -675,522.58 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 24.30 Mn |
| Mar 31, 2023 | 24.30 Mn |
| Mar 31, 2022 | 14.55 Mn |
| Mar 31, 2022 | 14.55 Mn |
| Dec 31, 2020 | 18.84 Mn |
| Dec 31, 2020 | 18.84 Mn |
| Sep 30, 2020 | 6.39 Mn |
| Sep 30, 2020 | 6.39 Mn |
| Dec 31, 2019 | -24.73 Mn |
| Dec 31, 2019 | -24.73 Mn |
| Sep 30, 2019 | 34.02 Mn |
| Sep 30, 2019 | 34.02 Mn |